Avantea Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 1

Avantea General Information

Description

Operator of a laboratory of advanced technologies intended for animal reproduction and biotechnological research. The company specializes in the development and application of assisted reproduction technologies in equine, bovine and buffalo as well as offers ovum pick-up-ICSI and ovum pick-up-IVF services, thereby enabling its clients to find novel methods in the field of reproductive biotechnology for livestock breeding and biomedicine effectively.

Contact Information

Website
www.avantea.it
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Via Porcellasco 7/F
  • 26100 Cremona(Cremona)
  • Italy
+39 0372
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Via Porcellasco 7/F
  • 26100 Cremona(Cremona)
  • Italy
+39 0372

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avantea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avantea‘s full profile, request access.

Request a free trial

Avantea Patents

Avantea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3510861-A2 Hypoallergenic food and medical products from genome edited livestock Inactive 22-Dec-2017
EP-3510861-A3 Hypoallergenic food and medical products from genome edited livestock Inactive 22-Dec-2017
EP-2921048-A1 Sus scrofa v2g: a safe-harbor site for long-term expression and high integration rate of transgenes in pig Active 21-Mar-2014
EP-2921048-B1 Sus scrofa v2g: a safe-harbor site for long-term expression and high integration rate of transgenes in pig Active 21-Mar-2014
EP-2844064-A1 Novel transgenic animal model of amyotrophic lateral sclerosis Active 04-May-2012 A01K67/0275
To view Avantea’s complete patent history, request access »

Avantea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avantea Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avantea‘s full profile, request access.

Request a free trial

Avantea Investments (1)

Avantea’s most recent deal was a Buyout/LBO with Equitechnic. The deal was made on 23-Apr-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Equitechnic 23-Apr-2026 Buyout/LBO Animal Husbandry
To view Avantea’s complete investments history, request access »

Avantea Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Equitechnic Notre-Dame-D'estrees-Corbon, France 1984

Avantea FAQs

  • When was Avantea founded?

    Avantea was founded in 2008.

  • Where is Avantea headquartered?

    Avantea is headquartered in Cremona, Italy.

  • What is the size of Avantea?

    Avantea has 16 total employees.

  • What industry is Avantea in?

    Avantea’s primary industry is Biotechnology.

  • Is Avantea a private or public company?

    Avantea is a Private company.

  • What is Avantea’s current revenue?

    The current revenue for Avantea is .

  • Who are Avantea’s investors?

    DeA Capital Alternative Funds has invested in Avantea.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process